JCI three-lens brief
Evidence-based stock research on JCI. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
JCI moved +0.13% overnight.
- Trading at 93% of its 52-week range — near the top of the band.
- Debt-to-equity of 73.3 — balance-sheet-heavy.
JCI closed at $141.92 (+0.13%) as of 2026-04-25. Market cap: $86.86B. P/E (trailing) 47.6. Concerns: trading at 93% of its 52-week range — near the top of the band.; debt-to-equity of 73.3 — balance-sheet-heavy.. Last quarter: Revenue $5.80B, net income $524.00M, free cash flow $2.76B.
Why three lenses on JCI, not one.
A single reasoning model has blind spots it doesn’t know about. We examine JCIacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/JCI" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath JCI brief"></iframe>